Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor–Induced Musculoskeletal Pain: SWOG S0927

PURPOSE: Musculoskeletal symptoms are the most common adverse effects of aromatase inhibitors (AIs) and can result in decreased quality of life and discontinuation of therapy. Omega-3 fatty acids (O3-FAs) can be effective in decreasing arthralgia resulting from rheumatologic conditions and reducing...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Hershman, Dawn L., Unger, Joseph M., Crew, Katherine D., Awad, Danielle, Dakhil, Shaker R., Gralow, Julie, Greenlee, Heather, Lew, Danika L., Minasian, Lori M., Till, Cathee, Wade, James L., Meyskens, Frank L., Moinpour, Carol M.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2015
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4451174/
https://ncbi.nlm.nih.gov/pubmed/25940724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.59.5595
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados